TIL Therapy Breakthrough: New Hope for Solid Tumor Treatment in 2025 Introduction Tumor-Infiltrating Lymphocytes (TILs) represent a groundbreaking advancement in solid cancer treatment, offering new hope to patients with remarkable response rates and extended survival outcomes. This innovative immunotherapy approach extracts immune cells
Tag: pembrolizumab combination
